English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Jump to
    • Buy Aurobindo Pharma; target of Rs 1300: ICICI Securities

      Buy Aurobindo Pharma; target of Rs 1300: ICICI Securities

      ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated August 06, 2025.

    • Buy Aurobindo Pharma; target of Rs 1300: Motilal Oswal

      Buy Aurobindo Pharma; target of Rs 1300: Motilal Oswal

      Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated August 05, 2025.

    • Buy Aurobindo Pharma; target of Rs 1300: Prabhudas Lilladher

      Buy Aurobindo Pharma; target of Rs 1300: Prabhudas Lilladher

      Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated August 06, 2025.

    • Buy Aurobindo Pharma; target of Rs 1440: Prabhudas Lilladher

      Buy Aurobindo Pharma; target of Rs 1440: Prabhudas Lilladher

      Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1440 in its research report dated May 27, 2025.

    • Buy Aurobindo Pharma; target of Rs 1510: Prabhudas Lilladher

      Buy Aurobindo Pharma; target of Rs 1510: Prabhudas Lilladher

      Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1510 in its research report dated February 10, 2025.

    • Buy Aurobindo Pharma; target of Rs 1445: ICICI Securities

      Buy Aurobindo Pharma; target of Rs 1445: ICICI Securities

      ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1445 in its research report dated February 08, 2025.

    • Buy Aurobindo Pharma; target of Rs 1591: KR Choksey

      Buy Aurobindo Pharma; target of Rs 1591: KR Choksey

      KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1591 in its research report dated February 10, 2025.

    • Buy Aurobindo Pharma; target of Rs 1540: Geojit Financial Services

      Buy Aurobindo Pharma; target of Rs 1540: Geojit Financial Services

      Geojit Financial Services is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1540 in its research report dated November 27, 2024.

    • Buy Aurobindo Pharma; target of Rs 1591: KR Choksey

      Buy Aurobindo Pharma; target of Rs 1591: KR Choksey

      KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1591 in its research report dated November 13, 2024.

    • Buy Aurobindo Pharma; target of Rs 1532: Sharekhan

      Buy Aurobindo Pharma; target of Rs 1532: Sharekhan

      Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1532 in its research report dated November 11, 2024.

    • Accumulate Aurobindo Pharma target of Rs 1475: Prabhudas Lilladher

      Accumulate Aurobindo Pharma target of Rs 1475: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1475 in its research report dated November 12, 2024.

    • Accumulate Aurobindo Pharma; target of Rs 1525: Prabhudas Lilladher

      Accumulate Aurobindo Pharma; target of Rs 1525: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1525 in its research report dated August 13, 2024.

    • Neutral Aurobindo Pharma; target of Rs 1500: Motilal Oswal

      Neutral Aurobindo Pharma; target of Rs 1500: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 1500 in its research report dated August 12, 2024.

    • Neutral Aurobindo Pharma; target of Rs 1300: Motilal Oswal

      Neutral Aurobindo Pharma; target of Rs 1300: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 1300 in its research report dated May 27, 2024.

    • Accumulate Aurobindo Pharma; target of Rs 1295: KR Choksey

      Accumulate Aurobindo Pharma; target of Rs 1295: KR Choksey

      KR Choksey recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1295 in its research report dated May 29, 2024.

    • Neutral Aurobindo Pharma; target of Rs 1180: Motilal Oswal

      Neutral Aurobindo Pharma; target of Rs 1180: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 1180 in its research report dated May 10, 2024.

    • Hold Aurobindo Pharma; target of Rs 1133: Sharekhan

      Hold Aurobindo Pharma; target of Rs 1133: Sharekhan

      Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 1133 in its research report dated February 20, 2024.

    • Accumulate Aurobindo Pharma; target of Rs 1120: Prabhudas Lilladher

      Accumulate Aurobindo Pharma; target of Rs 1120: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1120 in its research report dated February 13, 2024.

    • Accumulate Aurobindo Pharma; target of Rs 1065: Prabhudas Lilladher

      Accumulate Aurobindo Pharma; target of Rs 1065: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1065 in its research report dated November 11, 2023.

    • Neutral Aurobindo Pharma; target of Rs 970: Motilal Oswal

      Neutral Aurobindo Pharma; target of Rs 970: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 970 in its research report dated November 11, 2023.

    • Accumulate Aurobindo Pharma; target of Rs 907: KR Choksey

      Accumulate Aurobindo Pharma; target of Rs 907: KR Choksey

      KR Choksey recommended accumulate rating on Aurobindo Pharma with a target price of Rs 907 in its research report dated August 24, 2023.

    • Neutral Aurobindo Pharma; target of Rs 910: Motilal Oswal

      Neutral Aurobindo Pharma; target of Rs 910: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 910 in its research report dated August 14, 2023.

    • Accumulate Aurobindo Pharma; target of Rs 900: Prabhudas Lilladher

      Accumulate Aurobindo Pharma; target of Rs 900: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 900 in its research report dated August 14, 2023.

    • Hold Aurobindo Pharma; target of Rs 665: KR Choksey

      Hold Aurobindo Pharma; target of Rs 665: KR Choksey

      KR Choksey recommended hold rating on Aurobindo Pharma with a target price of Rs 665 in its research report dated May 31, 2023.

    • Hold Aurobindo Pharma; target of Rs 716: Sharekhan

      Hold Aurobindo Pharma; target of Rs 716: Sharekhan

      Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 716 in its research report dated May 30, 2023.

    « First«12345678»Last »
    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347